AstraZeneca opens $1 billion R&D center in Boston's Kendall Square
AstraZeneca opened an 18-story research and development facility in Cambridge's Kendall Square, representing a $1 billion investment that will expand the pharmaceutical company's Massachusetts workforce by over 50%. The new global strategic R&D center aims to advance next-generation medicines and includes robotic automation for scientific research.
4 sourcesLab automation
00